Pulse Biosciences Inc Valor Contábil/Ação
Qual é o Valor Contábil/Ação de Pulse Biosciences Inc?
O Valor Contábil/Ação de Pulse Biosciences Inc é 7.07
Qual é a definição de Valor Contábil/Ação?
O valor contábil por ação é um ativo da empresa menos as responsabilidades dividido pelo número de ações em circulação.
The book value of a company is the value of its assets according to its balance sheet account balance. For assets, the value is based on the original cost of the asset less any depreciation, amortization or impairment costs made against the asset. Traditionally, a company's book value is its total assets minus intangible assets and liabilities. However, in practice, depending on the source of the calculation, book value may variably include goodwill, intangible assets, or both. The value inherent in its workforce, part of the intellectual capital of a company, is always ignored. The book value of a company may be also referred as with the term net asset value.
The book value per share is the the balance sheet equity value divided by the number of shares outstanding at the date of the balance sheet. Book value per share can be used to generate a measure of comprehensive earnings, when the opening and closing values are reconciled. The sale of shares/units by a business increases the total book value. Book value per share will increase if the additional shares are issued at a price higher than the pre-existing book value per share. The purchase of its own shares by a business will decrease total book value. Book value per share will decrease if more is paid for them than was received when originally issued. Dividends paid out will decrease book value per share value.
Valor Contábil/Ação de empresas na Setor Health Care em NASDAQ em comparação com Pulse Biosciences Inc
O que Pulse Biosciences Inc faz?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Empresas com valor contábil/ação semelhantes a Pulse Biosciences Inc
- Nuverra Environmental Solutions Inc tem Valor Contábil/Ação de 7.05
- Shanghai Sanyou Medical Co tem Valor Contábil/Ação de 7.05
- Prospect Capital Corp tem Valor Contábil/Ação de 7.05
- Kearny tem Valor Contábil/Ação de 7.06
- Jinshang Bank Co tem Valor Contábil/Ação de 7.06
- America Movil, S.A.B. de C.V tem Valor Contábil/Ação de 7.06
- Pulse Biosciences Inc tem Valor Contábil/Ação de 7.07
- Berry Corp tem Valor Contábil/Ação de 7.07
- BAE Systems Plc tem Valor Contábil/Ação de 7.08
- Denali Therapeutics Inc tem Valor Contábil/Ação de 7.08
- Huadian Power International tem Valor Contábil/Ação de 7.09
- abrdn Australia Equity Fund Inc tem Valor Contábil/Ação de 7.09
- JNBY Design tem Valor Contábil/Ação de 7.10